Table 2

Baseline characteristics according to occurrence of an incident CVD event (coronary event, stroke, peripheral vascular event) and progression in renal status (defined as any increase in albuminuria level or progression to ESRD) during follow-up

	Incident CVD event		Progression in renal status
	Event	No event	Progressors	Nonprogressors
N	269	2,698	373	2,830
Age (years)	49 ± 10^*	37 ± 12	39 ± 12	38 ± 13
Age at onset (years)	17 ± 11	17 ± 11	15 ± 11^†	17 ± 11
HbA_1c (%)	8.8 ± 1.6^*	8.4 ± 1.5	9.4 ± 1.7^†	8.3 ± 1.4
Total cholesterol (mmol/L)	5.3 ± 1.2^*	4.9 ± 0.9	5.4 ± 1.3^†	4.9 ± 0.9
SBP (mmHg)	148 ± 20^*	132 ± 17	141 ± 21^†	132 ± 17
DBP (mmHg)	81 ± 10^*	79 ± 10	83 ± 10^†	79 ± 10
PP (mmHg)	66 ± 18^*	52 ± 14	58 ± 18^†	54 ± 15
Mean arterial pressure (mmHg)	90 ± 10^*	83 ± 9	89 ± 10^†	83 ± 9
History of CVD (%)	34^*	5	12^†	7
History of smoking (%)	60^*	40	61^†	39
Antihypertensive medication (%)	77^*	31	60^†	35
eGFR (mL/min/1.73 m²)	57 ± 33^*	90 ± 31	68 ± 41^†	88 ± 32
Diabetic nephropathy	59^*	15	NA	NA

Values are expressed as number, means ± SD, or percentage.
Patients with a kidney transplant are excluded from the CVD analysis.
eGFR, estimated glomerular filtration rate; NA, not applicable.
↵*P < 0.05 vs. no event.
↵†P < 0.05 vs. nonprogressors.